Mark Eickhoff

Senior Director, Operations

Mark Eickhoff joined Immunomic Therapeutics with over 20 years of progressive leadership experience in clinical operations, with a specialized focus in vaccine development. Throughout his career, Mr. Eickhoff has led global, cross-functional project teams across all phases of research, supporting complex programs and contributing to the advancement of large-scale biologics and vaccine initiatives. His background reflects deep operational expertise, strategic oversight, and a strong commitment to efficient, high-quality program execution.

Prior to joining Immunomic Therapeutics, Mr. Eickhoff held key roles at Novavax and AstraZeneca Biologics, where he supported major development programs and helped drive operational excellence across multiple research efforts. His work in these organizations strengthened his experience in coordinating multidisciplinary teams, navigating regulatory expectations, and ensuring effective delivery across diverse operational environments.

Mr. Eickhoff holds a Bachelor of Science degree in Biology from James Madison University and an MBA from Loyola University Maryland.